Jung-Yun Lee (Jung Yun Lee)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 75

Top Venues

Journal of gynecologic oncology

International journal of cancer

Yonsei medical journal

Cancers

Yonsei University

Seoul National University College of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Yonsei University Mar 01 2020

South Korea

Associate Professor :: Obstetrics and Gynecology

Yonsei University Mar 01 2015 - Feb 28 2020

South Korea

Assistant Professor :: Obstetrics and Gynecology

Seoul National University Hospital Mar 01 2013 - Feb 28 2015

South Korea

Fellow :: Obstetrics and Gynecology

Seoul National University Hospital Mar 01 2006 - Feb 28 2010

South Korea

Resident :: Obstetrics and Gynecology

Education History

Seoul National University College of Medicine Mar 01 2010 - Aug 31 2015

South Korea

PHD :: Obstetrics and Gynecology

Seoul National University College of Medicine Mar 01 2008 - Feb 28 2010

South Korea

MSC :: Obstetrics and Gynecology

Publications

Ana Oaknin, Jung-Yun Lee, Vicky Makker, Do Youn Oh, Susana Banerjee, Antonio Gonzáles Martin, Kyung Hae Jung, Iwona Lugowska, Luis Manso, Aránzazu Manzano Fernández, Bohuslav Melichar, Salvatore Siena, Daniil Stroyakovskiy, Anitra Fielding, Soham Puvvada, Ann Smith, Funda Meric-Bernstam
Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02. Advances in therapy (2024)
Seung Hyuck Jeon, Gihoon You, Jung-Yun Lee, You-Seung Chung, Kyungjin Park, Hyunjoo Kim, Jaehyoung Jeon, Youngkwang Kim, Woo-Chan Son, Da Som Jeong, Eui-Cheol Shin, Jung-Yun Lee, Dai Hoon Han, Jaeho Jung, Su-Hyung Park
Anti-4-1BB×PD-L1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD-1 Blockade. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Seung-Hyuk Shim, Jung-Yun Lee, Yoo Young Lee, Jeong-Yeol Park, Jung-Yun Lee, Se Ik Kim, Gwan Hee Han, Eun-Jung Yang, Joseph J Noh, Ga Won Yim, Joo Hyuk Son, Nam Kyeong Kim, Tae-Hyun Kim, Tae Wook Kong, Youn Jin Choi, Angela Cho, Hyunji Lim, Eun Bi Jang, Hyun Woong Cho, Dong Hoon Suh
Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer. Journal of gynecologic oncology 35 (2) (2024)
Seung-Hyuk Shim, Jung-Yun Lee, Yoo Young Lee, Jeong-Yeol Park, Jung-Yun Lee, Se Ik Kim, Gwan Hee Han, Eun-Jung Yang, Joseph J Noh, Ga Won Yim, Joo Hyuk Son, Nam Kyeong Kim, Tae-Hyun Kim, Tae Wook Kong, Youn Jin Choi, Angela Cho, Hyunji Lim, Eun Bi Jang, Hyun Woong Cho, Dong Hoon Suh
Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer. Journal of gynecologic oncology 35 (2) (2024)
Jung-Yun Lee, Hyun Woong Cho, Myong Cheol Lim, Chel Hun Choi, Jung-Yun Lee
OPERA: a phase II trial of oregovomab plus non-platinum chemotherapy in PARP inhibitor/platinum-resistant ovarian cancer. Future oncology (London, England) (2024)
Seung-Hyuk Shim, Jung-Yun Lee, Yoo Young Lee, Jeong-Yeol Park, Jung-Yun Lee, Se Ik Kim, Gwan Hee Han, Eun-Jung Yang, Joseph J Noh, Ga Won Yim, Joo Hyuk Son, Nam Kyeong Kim, Tae-Hyun Kim, Tae Wook Kong, Youn Jin Choi, Angela Cho, Hyunji Lim, Eun Bi Jang, Hyun Woong Cho, Dong Hoon Suh
Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer. Journal of gynecologic oncology (2024)
Seung-Hyuk Shim, Jung-Yun Lee, Yoo Young Lee, Jeong-Yeol Park, Jung-Yun Lee, Se Ik Kim, Gwan Hee Han, Eun-Jung Yang, Joseph J Noh, Ga Won Yim, Joo Hyuk Son, Nam Kyeong Kim, Tae-Hyun Kim, Tae Wook Kong, Youn Jin Choi, Angela Cho, Hyunji Lim, Eun Bi Jang, Hyun Woong Cho, Dong Hoon Suh
Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer. Journal of gynecologic oncology 35 (2) (2024)
Seung-Hyuk Shim, Jung-Yun Lee, Yoo Young Lee, Jeong-Yeol Park, Jung-Yun Lee, Se Ik Kim, Gwan Hee Han, Eun-Jung Yang, Joseph J Noh, Ga Won Yim, Joo Hyuk Son, Nam Kyeong Kim, Tae-Hyun Kim, Tae Wook Kong, Youn Jin Choi, Angela Cho, Hyunji Lim, Eun Bi Jang, Hyun Woong Cho, Dong Hoon Suh
Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer. Journal of gynecologic oncology 35 (2) (2024)
Young Joo Lee, Yoon Kyung Shin, Nae Ry Kim, Se Ik Kim, Yoo Young Lee, Jeong-Yeol Park, Jae-Weon Kim, Hyun Woong Cho, Jung-Yun Lee
Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy. Journal of gynecologic oncology (2024)
Young Joo Lee, Woo Jin Kim, Soomin Hong, Jung-Yun Lee, Jung-Yun Lee, Sang-Wun Kim, Sunghoon Kim, Young-Tae Kim, Eun Ji Nam
The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation. Journal of gynecologic oncology (2024)
Banghyun Lee, Suk-Joon Chang, Byung Su Kwon, Joo Hyuk Son, Myong Cheol Lim, Yun Hwan Kim, Shin Wha Lee, Chel Hun Choi, Kyung Jin Eoh, Jung-Yun Lee, Dong Hoon Suh, Yong-Beom Kim
Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines. Journal of gynecologic oncology 35 (1) (2023)
Yoo-Na Kim, Yun Soo Chung, Ji Hyun Lee, Eunhyang Park, Seung Tae Lee, Sunghoon Kim, Jung-Yun Lee
Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience. Journal of gynecologic oncology (2023)
Amany Abdelwadoud Makroum, Jung-Yun Lee, Jung-Yun Lee, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young-Tae Kim
Comparison of oncological outcomes between sentinel lymph node biopsy and complete lymphadenectomy for endometrial cancer. The journal of obstetrics and gynaecology research (2023)
Banghyun Lee, Suk-Joon Chang, Byung Su Kwon, Joo Hyuk Son, Myong Cheol Lim, Yun Hwan Kim, Shin Wha Lee, Chel Hun Choi, Kyung Jin Eoh, Jung-Yun Lee, Dong Hoon Suh, Yong-Beom Kim
Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines. Journal of gynecologic oncology 35 (1) (2023)
Ki Eun Seon, Jung-Yun Lee, Jung-Yun Lee, Eun Ji Nam, Sunghoon Kim, Young-Tae Kim, Sang-Wun Kim
Initial experience with the da Vinci SP robot-assisted surgical staging of endometrial cancer: a retrospective comparison with conventional laparotomy. Journal of robotic surgery (2023)
Jung-Yun Lee, Jung Bok Lee, Myong Cheol Lim, Byoung-Gie Kim, Jae-Weon Kim, Sunghoon Kim, Chel Hun Choi, Hee Seung Kim, Sang Yoon Park, Jung-Yun Lee, null null
Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D. Journal for immunotherapy of cancer 11 (10) (2023)
Jinho Heo, Yoo-Na Kim, Saeam Shin, Kyunglim Lee, Ji-Hyun Lee, Jung-Yun Lee, Zisun Choi, Jihyang Park, Seungki Min, Sang-Wun Kim, Jong Rak Choi, Sunghoon Kim, Seung Tae Lee, Jung-Yun Lee
Serial circulating-tumor DNA analysis with a tumor naïve next-generation sequencing panel detects minimal residual disease and predicts outcome in ovarian cancer. Cancer research (2023)
Banghyun Lee, Suk-Joon Chang, Byung Su Kwon, Joo Hyuk Son, Myong Cheol Lim, Yun Hwan Kim, Shin Wha Lee, Chel Hun Choi, Kyung Jin Eoh, Jung-Yun Lee, Dong Hoon Suh, Yong-Beom Kim
Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines. Journal of gynecologic oncology 35 (1) (2023)
Banghyun Lee, Suk-Joon Chang, Byung Su Kwon, Joo Hyuk Son, Myong Cheol Lim, Yun Hwan Kim, Shin Wha Lee, Chel Hun Choi, Kyung Jin Eoh, Jung-Yun Lee, Dong Hoon Suh, Yong-Beom Kim
Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines. Journal of gynecologic oncology 35 (1) (2023)
Jung-Yun Lee, Yoo Young Lee, Jeong-Yeol Park, Seung-Hyuk Shim, Se Ik Kim, Tae Wook Kong, Chul Kwon Lim, Hyun Woong Cho, Dong Hoon Suh
Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3. Journal of gynecologic oncology 34 (2) (2023)
Banghyun Lee, Suk-Joon Chang, Byung Su Kwon, Joo Hyuk Son, Myong Cheol Lim, Yun Hwan Kim, Shin Wha Lee, Chel Hun Choi, Kyung Jin Eoh, Jung-Yun Lee, Dong Hoon Suh, Yong-Beom Kim
Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines. Journal of gynecologic oncology 35 (1) (2023)
Kyeongmin Kim, Se-Hoon Kim, Jung-Yun Lee, Yoo-Na Kim, Seung Tae Lee, Eunhyang Park
RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma. Journal of gynecologic oncology (2023)
Yoo-Na Kim, Yeeun Shim, Jieun Seo, Zisun Choi, Jung-Yun Lee, Saeam Shin, Sang-Wun Kim, Sunghoon Kim, Jong Rak Choi, Jung-Yun Lee, Seung Tae Lee
Investigation of poly ADP-ribose polymerase inhibitor resistance based on serially collected circulating tumor DNA in patients with BRCA-mutated ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jung-Yun Lee, Yoo Young Lee, Jeong-Yeol Park, Seung-Hyuk Shim, Se Ik Kim, Tae Wook Kong, Chul Kwon Lim, Hyun Woong Cho, Dong Hoon Suh
Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3. Journal of gynecologic oncology 34 (2) (2023)
Yoo-Na Kim, Je-Gun Joung, Eunhyang Park, Jae-Weon Kim, Jung Bok Lee, Jinyeong Lim, Sunghoon Kim, Chel Hun Choi, Hee Seung Kim, Jongsuk Chung, Byoung-Gie Kim, Jung-Yun Lee
Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045. International journal of cancer (2023)
Yoo-Na Kim, Boram Park, Jae Weon Kim, Byoung Gie Kim, Sang-Wun Kim, Hee Seung Kim, Chel Hun Choi, Myong Cheol Lim, Natalie Yl Ngoi, David Sp Tan, Jung-Yun Lee
Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4. Nature communications 14 (1) (2023)
Yoo-Na Kim, Je-Gun Joung, Eunhyang Park, Jae-Weon Kim, Jung Bok Lee, Jinyeong Lim, Sunghoon Kim, Chel Hun Choi, Hee Seung Kim, Jongsuk Chung, Byoung-Gie Kim, Jung-Yun Lee
Reply to: Comments on "Randomized, two-arm, non-comparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045". International journal of cancer (2023)
Shannon Neville Westin, Kathleen Moore, Hye Sook Chon, Jung-Yun Lee, Jessica Thomes Pepin, Michael Sundborg, Ayelet Shai, Joseph de la Garza, Shin Nishio, Michael A Gold, Ke Wang, Kristi McIntyre, Todd D Tillmanns, Stephanie V Blank, Ji-Hong Liu, Michael McCollum, Fernando Contreras Mejia, Tadaaki Nishikawa, Kathryn Pennington, Zoltan Novak, Andreia Cristina de Melo, Jalid Sehouli, Dagmara Klasa-Mazurkiewicz, Christos Papadimitriou, Marta Gil-Martin, Birute Brasiuniene, Conor Donnelly, Paula Michelle Del Rosario, Xiaochun Liu, Els Van Nieuwenhuysen, null null
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jung-Yun Lee, Jung Chul Kim, Miran Lee, JooHyang Lee, Yoo-Na Kim, Yong Jae Lee, Sunghoon Kim, Sang Wun Kim, Su-Hyung Park, Jung-Yun Lee
Frequency of peripheral PD-1 + regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer. British journal of cancer (2023)
Jung-Yun Lee, Yoo Young Lee, Jeong-Yeol Park, Seung-Hyuk Shim, Se Ik Kim, Tae Wook Kong, Chul Kwon Lim, Hyun Woong Cho, Dong Hoon Suh
Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3. Journal of gynecologic oncology 34 (2) (2023)
Seung Hyuck Jeon, Minyong Kang, Minwoo Jeon, You-Seung Chung, A Reum Kim, Yong Joon Lee, Eui-Soon Kim, Heejin Nam, Jung-Yun Lee, Jung-Yun Lee, Eui-Cheol Shin, Seong Il Seo, Su-Hyung Park
CEACAM1 marks highly suppressive intratumoral regulatory T cells for targeted depletion therapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sang Hyun Cho, Jung-Yun Lee, Eun Ji Nam, Sunghoon Kim, Young-Tae Kim, Sang-Wun Kim
Comparison of Single-Port Laparoscopy with Other Surgical Approaches in Endometrial Cancer Surgical Staging: Propensity-Score-Matched Analysis. Cancers 15 (22) (2023)
Funda Meric-Bernstam, Vicky Makker, Ana Oaknin, Do Youn Oh, Susana Banerjee, Antonio Gonzáles Martin, Kyung Hae Jung, Iwona Ługowska, Luis Manso Sanchez, Aránzazu Manzano, Bohuslav Melichar, Salvatore Siena, Daniil Stroyakovskiy, Anitra Fielding, Yan Ma, Soham Puvvada, Norah Shire, Jung-Yun Lee
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Banghyun Lee, Suk-Joon Chang, Byung Su Kwon, Joo Hyuk Son, Myong Cheol Lim, Yun Hwan Kim, Shin Wha Lee, Chel Hun Choi, Kyung Jin Eoh, Jung-Yun Lee, Dong Hoon Suh, Yong-Beom Kim
Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines. Journal of gynecologic oncology (2023)
Banghyun Lee, Suk-Joon Chang, Byung Su Kwon, Joo Hyuk Son, Myong Cheol Lim, Yun Hwan Kim, Shin Wha Lee, Chel Hun Choi, Kyung Jin Eoh, Jung-Yun Lee, Dong Hoon Suh, Yong-Beom Kim
Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines. Journal of gynecologic oncology 35 (1) (2023)
Jung-Yun Lee, Young Shin Chung, Jung-Yun Lee, Eun Ji Nam, Sang-Wun Kim, Young-Tae Kim, Sunghoon Kim
Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer. Journal of gynecologic oncology 34 (2) (2022)
Jung-Yun Lee, Young Shin Chung, Jung-Yun Lee, Eun Ji Nam, Sang-Wun Kim, Young-Tae Kim, Sunghoon Kim
Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer. Journal of gynecologic oncology 34 (2) (2022)
Young Shin Chung, Yup Kim, Hyun Soo Kim, Jung-Yun Lee, Won Jun Kang, Sunghoon Kim, Sang-Wun Kim
Prognostic value of complete metabolic response on ¹⁸F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer. Journal of gynecologic oncology 33 (3) (2022)
Jung-Yun Lee, Young Shin Chung, Jung-Yun Lee, Eun Ji Nam, Sang-Wun Kim, Young-Tae Kim, Sunghoon Kim
Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer. Journal of gynecologic oncology (2022)
Jung-Yun Lee, Byoung Gie Kim, Jae-Weon Kim, Jung Bok Lee, Eunhyang Park, Je-Gun Joung, Sunghoon Kim, Chel Hun Choi, Hee Seung Kim, null null
Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial. Journal of gynecologic oncology 33 (4) (2022)
Yoo-Na Kim, Min Kyu Kim, Young Joo Lee, Youngeun Lee, Ji Yeon Sohn, Jung-Yun Lee, Min Chul Choi, Migang Kim, Sang Geun Jung, Won Duk Joo, Chan Lee
Identification of Lynch Syndrome in Patients with Endometrial Cancer Based on a Germline Next Generation Sequencing Multigene Panel Test. Cancers 14 (14) (2022)
Jung-Yun Lee, Ha Young Woo, Yoo-Na Kim, Jung-Yun Lee, Eun Ji Nam, Sang-Wun Kim, Sunghoon Kim, Young-Tae Kim, Eunhyang Park, Je-Gun Joung, Jung-Yun Lee
Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer. Cancers 14 (9) (2022)
Jung-Yun Lee, Young Shin Chung, Jung-Yun Lee, Eun Ji Nam, Sang-Wun Kim, Young-Tae Kim, Sunghoon Kim
Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer. Journal of gynecologic oncology 34 (2) (2022)
Jung-Yun Lee, Young Shin Chung, Jung-Yun Lee, Eun Ji Nam, Sang-Wun Kim, Young-Tae Kim, Sunghoon Kim
Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer. Journal of gynecologic oncology 34 (2) (2022)
Rowan E Miller, Karim Hussien El-Shakankery, Jung-Yun Lee
PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies. Journal of gynecologic oncology 33 (3) (2022)
Jeong-Yeol Park, Jung-Yun Lee, Yoo Young Lee, Seung-Hyuk Shim, Dong Hoon Suh, Jae-Weon Kim
Major clinical research advances in gynecologic cancer in 2021. Journal of gynecologic oncology 33 (2) (2022)
Galam Leem, Junsik Park, Minwoo Jeon, Eui-Soon Kim, Sang Wun Kim, Yong Jae Lee, Seong Jin Choi, Baekgyu Choi, Seongyeol Park, Young Seok Ju, Inkyung Jung, Sunghoon Kim, Eui-Cheol Shin, Jung-Yun Lee, Su-Hyung Park
4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39+ CD8 T cells from primary and metastatic sites of epithelial ovarian cancers. Journal for immunotherapy of cancer 8 (2) (2021)
Jung-Yun Lee, Myong Cheol Lim, Jae Kwan Lee, Dae Hoon Jeong, Se Ik Kim, Min Chul Choi, Byoung Gie Kim, Jung-Yun Lee
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial. Journal of gynecologic oncology 33 (2) (2021)
Na Young Kim, Dae Chul Jung, Jung-Yun Lee, Kyung Hwa Han, Young Taik Oh
CT-Based Fagotti Scoring System for Non-Invasive Prediction of Cytoreduction Surgery Outcome in Patients with Advanced Ovarian Cancer. Korean journal of radiology 22 (9) (2021)
Jung-Yun Lee, Myong Cheol Lim, Byoung Gie Kim, Natalie Yan Li Ngoi, Chel Hun Choi, Sang-Yoon Park, David Shao Peng Tan, Yunjung Go, Jung-Yun Lee
A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01). Journal of gynecologic oncology 32 (2) (2021)
Miseon Kim, Dong Hoon Suh, Kyung-Hun Lee, Keun Yong Eom, Jung-Yun Lee, Yoo Young Lee, Hanne Falk Hansen, Mansoor Raza Mirza, Jae-Weon Kim
Major clinical research advances in gynecologic cancer in 2019. Journal of gynecologic oncology 31 (3) (2021)
Hyeon Gu Kang, Haeun Hwangbo, Myung Ji Kim, Sinae Kim, Eun Ji Lee, Min Ji Park, Jae-Weon Kim, Byoung Gie Kim, Eun Hae Cho, Suhwan Chang, Jung-Yun Lee, Jung Kyoon Choi
Aberrant transcript usage is associated with homologous recombination deficiency and predicts therapeutic response. Cancer research (2021)
Jung-Yun Lee, Kyung Jin Eoh, Eun Ji Nam, Sunghoon Kim, Sang-Wun Kim, Young-Tae Kim, Jung-Yun Lee
A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer. Yonsei medical journal 61 (4) (2020)
Kyung Jin Min, Dong Hoon Suh, Tsukasa Baba, Xiao-Jun Chen, Jae-Weon Kim, Yusuke Kobayashi, Janice S Kwon, Myong Cheol Lim, Jung-Yun Lee, Satoru Nagase, Jeong-Yeol Park, Siriwan Tangjitgamol, Hidemichi Watari
Time for enhancing government-led primary prevention of cervical cancer. Journal of gynecologic oncology 32 (1) (2020)
Nalee Kim, Jee Suk Chang, Sang-Wun Kim, Gun Min Kim, Jung-Yun Lee, Yong Bae Kim
Involved-field radiation therapy for selected cases of recurrent ovarian cancer. Journal of gynecologic oncology 30 (5) (2020)
Sung-Jong Lee, Tae-Hun Kim, Miseon Kim, Dong Hoon Suh, Jeong-Yeol Park, Myong Cheol Lim, Jung-Yun Lee, Jae-Weon Kim, Yong Bae Kim, Keun Yong Eom, Seung Cheol Kim
Recommendations for gynecologic cancer care during the COVID-19 pandemic. Journal of gynecologic oncology 31 (4) (2020)
Jung-Yun Lee, Jae-Weon Kim, Myong Cheol Lim, Sunghoon Kim, Hee Seung Kim, Chel Hun Choi, Ju Yeon Yi, Sang-Yoon Park, Byoung Gie Kim, null null
A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D. Journal of gynecologic oncology 30 (6) (2020)
Yong J Lee, Dachan Kim, Jung E Shim, Su-Jin Bae, Yu-Jin Jung, Sora Kim, Hanna Lee, So H Kim, Su B Jo, Jung-Yun Lee, Hyun-Soo Kim, Soonmyung Paik
Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy. International journal of cancer 146 (7) (2019)
Yong Jae Lee, Young Shin Chung, Jung-Yun Lee, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, Young Tae Kim
Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced-stage ovarian cancer. Cancer medicine 8 (2) (2019)
Jung-Yun Lee, Jung-Yun Lee, Sunghoon Kim
How to use immune checkpoint inhibitor in ovarian cancer? Journal of gynecologic oncology 30 (5) (2019)
Yoo-Na Kim, Jung-Yun Lee, Jung-Yun Lee, Eun Ji Nam, Sang-Wun Kim, Sunghoon Kim, Young-Tae Kim
Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer. Journal of gynecologic oncology 31 (2) (2019)
Jung-Yun Lee, Dachan Kim, Hyun Soo Kim, Kiyong Na, Jung-Yun Lee, Eun Ji Nam, Sang-Wun Kim, Sunghoon Kim, Young-Tae Kim
Integrating a Next Generation Sequencing Panel into Clinical Practice in Ovarian Cancer. Yonsei medical journal 60 (10) (2019)
Tae Wook Kong, Hee-Sug Ryu, Seung Cheol Kim, Takayuki Enomoto, Jin Li, Kenneth H Kim, Seung-Hyuk Shim, Peng Hui Wang, Suwanit Therasakvichya, Yusuke Kobayashi, Maria Lee, Ting Yan Shi, Shin Wha Lee, Mikio Mikami, Satoshi Nagase, Myong Cheol Lim, Jianliu Wang, Sarikapan Wilailak, Sang-Wun Kim, Sook Hee Hong, David Shao Peng Tan, Masaki Mandai, Suk-Joon Chang, Ruby Yun-Ju Huang, Kimio Ushijma, Jung-Yun Lee, Xiaojun Chen, Kazunori Ochiai, Taek Sang Lee, Bingyi Yang, Farhana Kalam, Qiaoying Lv, Mohd Faizal Ahmad, Muhammad Rizki Yaznil, Kanika Batra Modi, Manatsawee Manopunya, Dae Hoon Jeong, Arb Aroon Lertkhachonsuk, Hyun Hoon Chung, Hidemichi Watari, Seob Jeon
Asian Society of Gynecologic Oncology International Workshop 2018. Journal of gynecologic oncology 30 (2) (2019)
Young Shin Chung, Jung-Yun Lee, Hyun Soo Kim, Eun Ji Nam, Sang Wun Kim, Young Tae Kim
Outcomes of Non-High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: Single-Institution Experience. Yonsei medical journal 59 (8) (2018)
Jung-Yun Lee, Jung-Yun Lee, Min Soo Cho, Eun Ji Nam, Sang-Wun Kim, Sunghoon Kim, Young-Tae Kim
Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study. Journal of gynecologic oncology 30 (1) (2018)
Yong Jae Lee, In Ha Lee, Yun-Ji Kim, Young Shin Chung, Jung-Yun Lee, Eun Ji Nam, Sunghoon Kim, Sang-Wun Kim, Young Tae Kim
Evaluation of various kinetic parameters of CA-125 in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy. PloS one 13 (9) (2018)
Yun-Ji Kim, Inha Lee, Young Shin Chung, EunJi Nam, Sunghoon Kim, Sang-Wun Kim, Young Tae Kim, Jung-Yun Lee
Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer. Obstetrics & gynecology science 61 (2) (2018)
In Ok Lee, Jung-Yun Lee, Sunghoon Kim, Sang-Wun Kim, Young Tae Kim, Eun Ji Nam
Sentinel lymph node mapping with indocyanine green in vaginal cancer. Journal of gynecologic oncology 28 (4) (2018)
Kyung Jin Eoh, Jung-Yun Lee, Eun Ji Nam, Sunghoon Kim, Young-Tae Kim, Sang-Wun Kim
Periumbilical infiltration of lidocaine with epinephrine for postoperative pain reduction in single-port laparoscopic adnexal surgery. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 38 (8) (2018)
Kyung Jin Eoh, Jung-Yun Lee, Eun Ji Nam, Sunghoon Kim, Young-Tae Kim, Sang-Wun Kim
Long-Term Survival Analysis of Intraperitoneal versus Intravenous Chemotherapy for Primary Ovarian Cancer and Comparison between Carboplatin- and Cisplatin-based Intraperitoneal Chemotherapy. Journal of Korean medical science 32 (12) (2018)
Jung-Yun Lee, Young Shin Chung, Jung-Yun Lee, Eun Ji Nam, Sang-Wun Kim, Sunghoon Kim, Young-Tae Kim
Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center. Journal of gynecologic oncology 29 (4) (2018)
Young Shin Chung, Yun-Ji Kim, Inha Lee, Jung-Yun Lee, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim
Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer. PloS one 12 (9) (2017)
Myong Cheol Lim, Maria Lee, Seung-Hyuk Shim, Eun Ji Nam, Jung-Yun Lee, Hyun Jung Kim, Yoo Young Lee, Kwang Beom Lee, Jeong-Yeol Park, Yun Hwan Kim, Kyung Do Ki, Yong Jung Song, Hyun Hoon Chung, Sunghoon Kim, Jeong-Won Lee, Jae-Weon Kim, Duk Soo Bae, Jong Min Lee
Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement. Journal of gynecologic oncology 28 (3) (2017)
Jung-Yun Lee, Young Shin Chung, Kiyong Na, Hye Min Kim, Cheol Keun Park, Eun Ji Nam, Sunghoon Kim, Sang-Wun Kim, Young Tae Kim, Hyun Soo Kim
External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma. Journal of gynecologic oncology 28 (6) (2017)
Seob Jeon, Sung-Jong Lee, Myong Cheol Lim, Taejong Song, Jae Man Bae, Kidong Kim, Jung-Yun Lee, Sang-Wun Kim, Suk-Joon Chang, Jong Min Lee
Surgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancers. Journal of gynecologic oncology 28 (1) (2016)

Jung-Yun Lee.css-eqlu8i{font-size:small;padding-left:4px;} (Jung Yun Lee)

Publication Activity (10 Years)

Top Topics

Top Venues

Jung-Yun Lee (Jung Yun Lee)